# The Non-Psychoactive Cannabis Constituent Cannabidiol as an Oral Anti-Arthritic Therapeutic in Murine Arthritis > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabidiol-oral-anti-arthritic-therapeutic/ > **Published:** 2022-08-16T19:40:07-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:16:30-04:00 > **Clinical Summary:** Explore cannabidiol oral anti-arthritic therapeutic effects in murine models, highlighting its immune modulation and anti-inflammatory benefits. --- Many cannabinoids, the biologically active components of marijuana, are known to interact with and modulate human’s [immune system](https://cedclinic.com/fungal-contamination-cannabis-risks-arizona-preroll-recall/). Among the 2 major marijuana-derived cannabinoids, (Δ9-tetrahydrocannabinol) THC also acts on human’s brain and is therefore responsible for the “high” sensation while cannabidiol (CBD) doesn’t. These reasons have prompted interest into CBD as a potential safe and effective therapy for diseases that involve abnormal activities of the [immune system](https://cedclinic.com/fungal-contamination-cannabis-risks-arizona-preroll-recall/), most noticeably arthritis. To study the therapeutic effects of CBD in arthritis, researchers employed murine models. Mice were induced to exhibit either acute arthritis or chronic arthritis and after onset of clinical symptoms, were given CBD. In both models of the disease, the treatment was found to effectively block [disease progression](https://cedclinic.com/multiple-sclerosis-biomarkers-p21-protein-variations/), as evidenced through its protection of the joints against severe damage. Further experiments elucidated the mechanism of these [therapeutic benefits](https://cedclinic.com/therapeutic-benefits-of-thc/): Draining lymph node cells from CBD-treated mice showed a diminished IFN-ɣ production, as well as a decreased release of TNF-ɑ, both of which are small molecules responsible for inflammation through activating the immune system. Furthermore, CBD suppressed the proliferation of lymphocytes – the main cells of the immune system. Finally, experiments also suggested that in mice, CBD was equally effective when administered intraperitoneally (i.e. inject into the body cavity) or orally. In short, research has shown that CBD, through its combined immunosuppressive and anti-inflammatory actions, possesses a potent anti-arthritic effect. Since it also boasts a good safety profile and can be easily administered orally, CBD is a promising drug candidate for patients suffering from painful symptoms of arthritis. Have you found CBD to be helpful for your arthritis pain? We’d like to hear about your experience! [More access here](https://cedclinic.com/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [The synthetic cannabinoid WIN55,212-2 mesylate decreases the production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts by acti](https://cedclinic.com/synthetic-cannabinoid-win55212-2-mesylate-rheumatoid-arthritis/) This study explores how [synthetic cannabinoids](https://cedclinic.com/synthetic-cannabinoid-parkinsons-trial-ser-252-funding/) reduce inflammatory mediators in rheumatoid arthritis, complementing cannabidiol's anti-inflammatory potential. [Read More](https://cedclinic.com/synthetic-cannabinoid-win55212-2-mesylate-rheumatoid-arthritis/) [Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psori](https://cedclinic.com/cannabinoids-inhibit-keratinocyte-proliferation-non-cb1-cb2/) Research on cannabinoids' therapeutic effects in skin conditions highlights their broader anti-inflammatory and immunomodulatory roles. [Explore Article](https://cedclinic.com/cannabinoids-inhibit-keratinocyte-proliferation-non-cb1-cb2/) [Natural Approaches to Managing Chronic Inflammation – WorldHealth.net](https://cedclinic.com/endocannabinoid-system-chronic-inflammation/) An overview of natural strategies to manage chronic inflammation, providing context for cannabidiol's role as an anti-inflammatory agent. [Learn More](https://cedclinic.com/endocannabinoid-system-chronic-inflammation/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=The%20Non-Psychoactive%20Cannabis%20Constituent%20Cannabidiol%20as%20an%20Oral%20Anti-Arthritic%20Therapeutic%20in%20Murine%20Arthritis&url=https%3A%2F%2Fcedclinic.com%2Fcannabidiol-oral-anti-arthritic-therapeutic%2F) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fcannabidiol-oral-anti-arthritic-therapeutic%2F) [Share on BlueSky](https://bsky.app/intent/compose?text=The%20Non-Psychoactive%20Cannabis%20Constituent%20Cannabidiol%20as%20an%20Oral%20Anti-Arthritic%20Therapeutic%20in%20Murine%20Arthritis%20https%3A%2F%2Fcedclinic.com%2Fcannabidiol-oral-anti-arthritic-therapeutic%2F) [Follow on Instagram](https://www.instagram.com/drbenjamincaplan) [Read more on Substack](https://doctorapprovedcannabis.substack.com/) [Subscribe via RSS](https://cedclinic.com/feed/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).